The United States Supreme Court recently declined to review the Food and Drug Administration’s (FDA) decision to reject an application by Avail Vapor to market flavored electronic cigarettes. This move by the Supreme Court anchors the FDA’s contested win, which Avail Vapor claimed came from last-minute changes to the application process for new tobacco products. The accusation went as far as alleging that such changes led to the denial of 99% of e-cigarette submissions.
This decision comes as a significant blow to Avail Vapor and similar businesses that hoped the Supreme Court would consider their plea against the FDA’s alleged impromptu changes. From their perspective, many adult smokers use e-cigarettes in an attempt to stop smoking more harmful traditional tobacco products.
Earlier, the US Court of Appeals for the Fourth Circuit sided with the FDA, finding that Avail Vapor had not sufficiently demonstrated that its products tendered benefits for adult users that could counterbalance the risks posed to younger demographics. The US Supreme Court’s refusal to review the case underscores the veracity of this earlier ruling.
The full implications of this unchallenged FDA victory will evidently ripple across the e-cigarette industry – especially those hoping to market flavored products. It stands as a testament to the legal robustness of the FDA’s rigorous application process and its commitment to maintaining a careful balance between adult users’ benefits and the risks to younger consumers.
For the full report on this topic, read the original story on Bloomberg Law.